首页> 外国专利> PEPTIDE ORIGINATED FROM POLO-LIKE KINASE C-TERMINAL AND THEIR USE IN SCREENING OF PLK1 TARGET PROTEINS

PEPTIDE ORIGINATED FROM POLO-LIKE KINASE C-TERMINAL AND THEIR USE IN SCREENING OF PLK1 TARGET PROTEINS

机译:源于多聚类激酶C末端的肽及其在PLK1靶蛋白筛选中的用途

摘要

invention Plk1 (Polo-like kinase) of the C-terminal amino acid sequence derived from the inclusion of It relates to a peptide and a screening method of Plk1 target protein using the same. Specifically, the 410 to 439th amino acid sequence located at the C- terminal of Plk1 (Polo-like kinase) plays an important function across similar cleavable groups of the cell cycle It relates to a peptide and a peptide containing the organelles of the core body (centrosome) and screening methods using as an intermediate (midbody) or Plk1 molecule that can specifically recognize the target protein marker (marker). A peptide of the present invention is combined with the target protein easy least motif (motif), cells useful for the screening of proteins that bind and Plk1 and Plk1 plays an important role in the growth process of the cancer cells as well as the proliferation of normal cells to a target period can be efficiently used for screening of controlled substances, diagnostic and Plk1 in cancer tissues may be used for a variety of anti-cancer agents or drugs useful in the navigation system of the target.
机译:发明内容源自Plk1的C末端氨基酸序列的Plk1(Polo样激酶)涉及一种肽以及使用该肽的Plk1靶蛋白的筛选方法。具体而言,位于Plk1(Polo样激酶)C末端的410至439位氨基酸序列在细胞周期的类似可裂解基团中起着重要的作用。它涉及一种肽和一种含有核心体细胞器的肽(中心体)和使用作为中间物(中体)或Plk1分子的筛选方法,可以特异性识别目标蛋白标记(标记)。本发明的肽与靶蛋白最不易修饰基序(基序)结合,用于筛选结合蛋白的细胞,并且Plk1和Plk1在癌细胞的生长过程以及癌细胞的增殖中起重要作用。正常细胞至目标时期可以有效地用于筛查受控物质,诊断和癌组织中的Plk1可以用于多种抗癌药或可用于目标导航系统的药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号